01523 Overview

Market Performance: The Chinese stock market saw a rebound in January, with the HSI/ MSCI China Index increasing by 6.9% and 5% MoM, despite a significant sell-off by the 'National Team' amounting to US$68 billion.

Top Performers: WUXI BIO and PLOVER BAY TECH were highlighted as top performers with returns of 17.7% and 16.6%, respectively, while several stocks, including Alibaba and Ganfeng Lithium, were added to the Buy list.

Volatility Outlook: UOB Kay Hian anticipates continued market volatility in February due to recent corrections in gold and silver prices, but maintains a positive medium-term outlook supported by macro policies.

Stock Recommendations: The broker updated its recommendations, adding stocks like Alibaba and Ganfeng Lithium to the Buy list, while placing Meituan on the Sell list, and noted the need to cut losses on several other stocks.